IBRX logo

ImmunityBio (IBRX) Operating expenses

annual operating expenses:

$358.93M-$3.06M(-0.85%)
December 31, 2024

Summary

  • As of today (June 24, 2025), IBRX annual total operating expenses is $358.93 million, with the most recent change of -$3.06 million (-0.85%) on December 31, 2024.
  • During the last 3 years, IBRX annual operating expenses has risen by +$27.71 million (+8.37%).
  • IBRX annual operating expenses is now -0.85% below its all-time high of $361.99 million, reached on December 31, 2023.

Performance

IBRX Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIBRXincome statement metrics

quarterly operating expenses:

$80.89M+$3.94M(+5.11%)
March 31, 2025

Summary

  • As of today (June 24, 2025), IBRX quarterly total operating expenses is $80.89 million, with the most recent change of +$3.94 million (+5.11%) on March 31, 2025.
  • Over the past year, IBRX quarterly operating expenses has dropped by -$14.35 million (-15.07%).
  • IBRX quarterly operating expenses is now -27.74% below its all-time high of $111.94 million, reached on March 31, 2023.

Performance

IBRX quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIBRXincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

IBRX Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.8%-15.1%
3 y3 years+8.4%-15.7%
5 y5 years+126.5%+119.4%

IBRX Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.8%+8.4%-27.7%+5.1%
5 y5-year-0.8%+126.5%-27.7%+119.4%
alltimeall time-0.8%+126.5%-27.7%+119.4%

IBRX Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$80.89M(+5.1%)
Dec 2024
$358.93M(-0.8%)
$76.95M(-10.9%)
Sep 2024
-
$86.36M(-14.0%)
Jun 2024
-
$100.38M(+5.4%)
Mar 2024
-
$95.24M(+12.5%)
Dec 2023
$361.99M(+3.2%)
$84.64M(+5.5%)
Sep 2023
-
$80.22M(-5.8%)
Jun 2023
-
$85.19M(-23.9%)
Mar 2023
-
$111.94M(+32.8%)
Dec 2022
$350.86M
$84.29M(-7.3%)
Sep 2022
-
$90.92M(+14.1%)
DateAnnualQuarterly
Jun 2022
-
$79.66M(-17.0%)
Mar 2022
-
$95.99M(+20.5%)
Dec 2021
$331.21M(+57.1%)
$79.66M(+1.0%)
Sep 2021
-
$78.90M(-8.5%)
Jun 2021
-
$86.25M(-0.2%)
Mar 2021
-
$86.40M(+28.5%)
Dec 2020
$210.82M(+33.1%)
$67.24M(+21.4%)
Sep 2020
-
$55.37M(+7.8%)
Jun 2020
-
$51.35M(+39.3%)
Mar 2020
-
$36.87M
Dec 2019
$158.45M
-

FAQ

  • What is ImmunityBio annual total operating expenses?
  • What is the all time high annual operating expenses for ImmunityBio?
  • What is ImmunityBio annual operating expenses year-on-year change?
  • What is ImmunityBio quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for ImmunityBio?
  • What is ImmunityBio quarterly operating expenses year-on-year change?

What is ImmunityBio annual total operating expenses?

The current annual operating expenses of IBRX is $358.93M

What is the all time high annual operating expenses for ImmunityBio?

ImmunityBio all-time high annual total operating expenses is $361.99M

What is ImmunityBio annual operating expenses year-on-year change?

Over the past year, IBRX annual total operating expenses has changed by -$3.06M (-0.85%)

What is ImmunityBio quarterly total operating expenses?

The current quarterly operating expenses of IBRX is $80.89M

What is the all time high quarterly operating expenses for ImmunityBio?

ImmunityBio all-time high quarterly total operating expenses is $111.94M

What is ImmunityBio quarterly operating expenses year-on-year change?

Over the past year, IBRX quarterly total operating expenses has changed by -$14.35M (-15.07%)
On this page